4/A: MAIA CEO Amends Form 4 for Spouse's Share Balance

MAIA Biotechnology's CEO, Vlad Vitoc, filed an amended Form 4 to correct the reported share balance beneficially owned by his spouse.

Summary

• Vlad Vitoc, Chief Executive Officer, Director, and 10% Owner of MAIA Biotechnology, Inc. (MAIA), filed an amended Form 4.
• The amendment corrects the previously reported total share balance beneficially owned by Mr. Vitoc's spouse.
• The original Form 4 was filed on November 28, 2025, and this amended form was signed on December 3, 2025.
• The filing also reports a direct acquisition of 10,500 shares of Common Stock by Mr. Vitoc on November 25, 2025, at a price of $0.9661 per share.
• Following this transaction, Mr. Vitoc directly owns 831,421 shares and indirectly owns 210,100 shares through his spouse.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive. The correction of a minor administrative error is offset by the positive signal of an insider share purchase by the CEO, indicating confidence in the company.

Positives

• CEO Vlad Vitoc acquired 10,500 shares of common stock at $0.9661 per share, indicating management's confidence in the company's future.

Negatives

• The necessity of an amendment to correct a share balance suggests a minor administrative error in the initial filing.

Stakeholder Impact

• Shareholders may view the CEO's direct purchase of additional shares as a positive signal of management's confidence in the company's prospects.

Key Dates

Recommendation

The CEO's direct purchase of additional shares signals management confidence, which is generally a positive indicator. However, this Form 4/A primarily addresses an administrative correction regarding indirect ownership, and does not provide sufficient comprehensive financial or operational data to warrant a 'buy' or 'sell' recommendation. Investors should consider this insider activity as one data point among broader due diligence.

Keywords

MAIA Biotechnology, MAIA, Vlad Vitoc, Insider Trading, Form 4/A, CEO, Director, 10% Owner, Stock Purchase, Beneficial Ownership